Chesley Taft & Associates’s Colgate-Palmolive CL Stock Holding History

Chesley Taft & Associates’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Sell	2,353 -5,968	-72%	-$522K	0.01%	360
2026 Q1	$709K	Sell	8,321 -160	-2%	-$14.3K	0.03%	246
2025 Q4	$670K	Buy	8,481 +48	+0.6%	+$3.76K	0.03%	257
2025 Q3	$674K	Hold	8,433	–	–	0.03%	246
2025 Q2	$767K	Sell	8,433 -133	-2%	-$12.1K	0.03%	227
2025 Q1	$803K	Hold	8,566	–	–	0.04%	220
2024 Q4	$779K	Hold	8,566	–	–	0.04%	221
2024 Q3	$889K	Hold	8,566	–	–	0.04%	206
2024 Q2	$831K	Sell	8,566 -275	-3%	-$25.4K	0.04%	204
2024 Q1	$796K	Hold	8,841	–	–	0.04%	208
2023 Q4	$705K	Sell	8,841 -25	-0.3%	-$1.88K	0.04%	212
2023 Q3	$630K	Hold	8,866	–	–	0.04%	209
2023 Q2	$683K	Hold	8,866	–	–	0.04%	205
2023 Q1	$666K	Sell	8,866 -150	-2%	-$11.2K	0.04%	205
2022 Q4	$710K	Hold	9,016	–	–	0.05%	196
2022 Q3	$633K	Hold	9,016	–	–	0.05%	198
2022 Q2	$723K	Hold	9,016	–	–	0.05%	200
2022 Q1	$730K	Hold	9,016	–	–	0.04%	210
2021 Q4	$769K	Hold	9,016	–	–	0.04%	200
2021 Q3	$681K	Sell	9,016 -40	-0.4%	-$3.18K	0.04%	205
2021 Q2	$737K	Sell	9,056 -400	-4%	-$32.7K	0.04%	200
2021 Q1	$752K	Sell	9,456 -10	-0.1%	-$784	0.04%	190
2020 Q4	$809K	Hold	9,466	–	–	0.05%	181
2020 Q3	$730K	Sell	9,466 -130	-1%	-$9.91K	0.05%	180
2020 Q2	$703K	Sell	9,596 -240	-2%	-$17K	0.05%	176
2020 Q1	$653K	Sell	9,836 -330	-3%	-$23.3K	0.06%	172
2019 Q4	$700K	Hold	10,166	–	–	0.05%	186
2019 Q3	$747K	Hold	10,166	–	–	0.06%	178
2019 Q2	$729K	Sell	10,166 -450	-4%	-$31.9K	0.06%	177
2019 Q1	$728K	Sell	10,616 -576	-5%	-$37.2K	0.06%	179
2018 Q4	$666K	Sell	11,192 -350	-3%	-$21.9K	0.06%	181
2018 Q3	$773K	Sell	11,542 -1,200	-9%	-$79.9K	0.06%	191
2018 Q2	$826K	Sell	12,742 -13,780	-52%	-$901K	0.07%	179
2018 Q1	$1.9M	Sell	26,522 -1,845	-7%	-$133K	0.17%	118
2017 Q4	$2.14M	Sell	28,367 -705	-2%	-$51.5K	0.18%	114
2017 Q3	$2.12M	Buy	29,072 +310	+1%	+$22.3K	0.18%	113
2017 Q2	$2.13M	Buy	28,762 +565	+2%	+$41.9K	0.19%	108
2017 Q1	$2.06M	Buy	28,197 +225	+0.8%	+$15.8K	0.19%	108
2016 Q4	$1.83M	Buy	27,972 +1,780	+7%	+$122K	0.18%	108
2016 Q3	$1.94M	Buy	26,192 +385	+1%	+$28.5K	0.2%	100
2016 Q2	$1.89M	Sell	25,807 -995	-4%	-$70.8K	0.19%	106
2016 Q1	$1.89M	Buy	26,802 +7,005	+35%	+$466K	0.2%	100
2015 Q4	$1.32M	Sell	19,797 -8,150	-29%	-$542K	0.14%	123
2015 Q3	$1.77M	Buy	27,947 +350	+1%	+$22.9K	0.19%	99
2015 Q2	$1.8M	Sell	27,597 -250	-0.9%	-$17K	0.18%	106
2015 Q1	$1.93M	Buy	27,847 +34	+0.1%	+$2.35K	0.2%	106
2014 Q4	$1.92M	Buy	27,813 +550	+2%	+$37.1K	0.19%	110
2014 Q3	$1.78M	Buy	27,263 +425	+2%	+$28K	0.19%	111
2014 Q2	$1.83M	Buy	26,838 +3,271	+14%	+$219K	0.19%	110
2014 Q1	$1.53M	Hold	23,567	–	–	0.16%	118
2013 Q4	$1.54M	Sell	23,567 -50	-0.2%	-$3.2K	0.15%	128
2013 Q3	$1.4M	Buy	23,617 +25	+0.1%	+$1.48K	0.15%	132
2013 Q2	$1.35M	Buy	+23,592	New	+$1.4M	0.16%	132

Other funds holding CL

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Chesley Taft & Associates's CL Position: Q2 2026 in Review

Chesley Taft & Associates reduced its Colgate-Palmolive (CL) stake by 72% in Q2 2026, selling an estimated $522K and leaving 2,353 shares worth $216K. The position accounts for 0.01% of the portfolio, ranked #360.

Chesley Taft & Associates first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.14M in Q4 2017. 847 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Chesley Taft & Associates held 2,353 shares of Colgate-Palmolive worth $216K as of Q2 2026.
Chesley Taft & Associates sold 5,968 Colgate-Palmolive shares in Q2 2026, an estimated $522K.
Colgate-Palmolive made up 0.01% of Chesley Taft & Associates's portfolio in Q2 2026, its #360 holding.
Chesley Taft & Associates first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
Chesley Taft & Associates's Colgate-Palmolive position peaked at $2.14M in Q4 2017.
847 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.